Literature DB >> 2556796

Molecular cloning of the thyrotropin receptor.

M Parmentier1, F Libert, C Maenhaut, A Lefort, C Gérard, J Perret, J Van Sande, J E Dumont, G Vassart.   

Abstract

The pituitary hormone thyrotropin, or thyroid-stimulating hormone (TSH), is the main physiological agent that regulates the thyroid gland. The thyrotropin receptor (TSHR) was cloned by selective amplification with the polymerase chain reaction of DNA segments presenting sequence similarity with genes for G protein-coupled receptors. Out of 11 new putative receptor clones obtained from genomic DNA, one had sequence characteristics different from all the others. Although this clone did not hybridize to thyroid transcripts, screening of a dog thyroid complementary DNA (cDNA) library at moderate stringency identified a cDNA encoding a 4.9-kilobase thyroid-specific transcript. The polypeptide encoded by this thyroid-specific transcript consisted of a 398-amino acid residue amino-terminal segment, constituting a putative extracellular domain, connected to a 346-residue carboxyl-terminal domain that contained seven putative transmembrane segments. Expression of the cDNA conferred TSH responsiveness to Xenopus oocytes and Y1 cells and a TSH binding phenotype to COS cells. The TSHR and the receptor for luteinizing hormone-choriogonadotropin constitute a subfamily of G protein-coupled receptors with distinct sequence characteristics.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2556796     DOI: 10.1126/science.2556796

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  87 in total

Review 1.  The TSH receptor reveals itself.

Authors:  Terry Davies; Russell Marians; Rauf Latif
Journal:  J Clin Invest       Date:  2002-07       Impact factor: 14.808

2.  Synthetic peptides based upon a three-dimensional model for the receptor recognition site of follicle-stimulating hormone exhibit antagonistic or agonistic activity at low concentrations.

Authors:  M Hage-van Noort; W C Puijk; H H Plasman; D Kuperus; W M Schaaper; N J Beekman; J A Grootegoed; R H Meloen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-05-01       Impact factor: 11.205

3.  Consecutive mutational events in a TSHR allele of Arab families with resistance to thyroid stimulating hormone.

Authors:  Chutintorn Sriphrapradang; Alina German; Alexandra M Dumitrescu; Samuel Refetoff
Journal:  Thyroid       Date:  2012-02-07       Impact factor: 6.568

Review 4.  Orphan G protein-coupled receptors (GPCRs): biological functions and potential drug targets.

Authors:  Xiao-long Tang; Ying Wang; Da-li Li; Jian Luo; Ming-yao Liu
Journal:  Acta Pharmacol Sin       Date:  2012-02-27       Impact factor: 6.150

Review 5.  Use of Xenopus oocytes for the functional expression of plasma membrane proteins.

Authors:  E Sigel
Journal:  J Membr Biol       Date:  1990-09       Impact factor: 1.843

6.  Nucleotide sequence of a human cannabinoid receptor cDNA.

Authors:  C Gérard; C Mollereau; G Vassart; M Parmentier
Journal:  Nucleic Acids Res       Date:  1990-12-11       Impact factor: 16.971

Review 7.  An update on diagnostic methods in the investigation of diseases of the thyroid.

Authors:  M J Reinhardt; E Moser
Journal:  Eur J Nucl Med       Date:  1996-05

8.  The Activation Mechanism of Glycoprotein Hormone Receptors with Implications in the Cause and Therapy of Endocrine Diseases.

Authors:  Antje Brüser; Angela Schulz; Sven Rothemund; Albert Ricken; Davide Calebiro; Gunnar Kleinau; Torsten Schöneberg
Journal:  J Biol Chem       Date:  2015-11-18       Impact factor: 5.157

9.  Disrupted TSH Receptor Expression in Female Mouse Lung Fibroblasts Alters Subcellular IGF-1 Receptor Distribution.

Authors:  Stephen J Atkins; Stephen I Lentz; Roshini Fernando; Terry J Smith
Journal:  Endocrinology       Date:  2015-09-21       Impact factor: 4.736

Review 10.  Thyrotropin receptor-associated diseases: from adenomata to Graves disease.

Authors:  Terry F Davies; Takao Ando; Reigh-Yi Lin; Yaron Tomer; Rauf Latif
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.